Blog

Enhancing Patient Safety with EPCS: A High-Level Overview

EPCS

Effective January 1st of 2023, the Centers for Medicare and Medicaid Services (CMS) mandated the use of electronic prescribing of controlled substances (EPCS). This mandate means all schedule II, III, IV, and V controlled substance prescriptions under the Medicare Part D plan are required to be submitted electronically. EPCS is a technological advancement that significantly improves patient safety and the efficiency of the prescribing process. Here’s a look at how EPCS achieves this through robust identity checks, accurate transmission of prescriptions, and timely delivery to pharmacies.

1. Enhanced Patient Safety

2. Reduction in Prescriber Burden

3. Dosespot: A Leading EPCS Solution

DoseSpot is at the forefront of EPCS solutions, offering a robust platform that integrates with EHR systems to provide secure, efficient, and accurate e-prescribing for controlled substances. DoseSpot’s features include:

In summary, EPCS enhances patient safety by ensuring accurate, timely, and secure prescription processes. It also reduces the administrative burden on prescribers and decreases unnecessary communication with pharmacies. Solutions like DoseSpot play a crucial role in driving the adoption of EPCS, enhancing patient care and safety while ensuring practitioners and practice management remain compliant with federal and state regulations.